FDA News

FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

Details
Category: FDA
Hits: 123
The FDA has approved a new indication for drug to treat seizures associated with tuberous sclerosis complex. The FDA has approved a new indication for drug to treat seizures associated with tuberous sclerosis complex.

Content Original Link:

http://www.fda.gov/news-events/press-announcements/fda-approves-new-indication-drug-containing-active-ingredient-derived-cannabis-treat-seizures-rare